Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+6.66%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$15.1B
AUM Growth
+$741M
Cap. Flow
-$213M
Cap. Flow %
-1.41%
Top 10 Hldgs %
36.34%
Holding
1,384
New
57
Increased
578
Reduced
363
Closed
33

Sector Composition

1 Real Estate 54.3%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VOO icon
1201
Vanguard S&P 500 ETF
VOO
$728B
0
ALEC icon
1202
Alector
ALEC
$305M
$2K ﹤0.01%
277
AMRN
1203
Amarin Corp
AMRN
$317M
$2K ﹤0.01%
67
ANAB icon
1204
AnaptysBio
ANAB
$613M
$2K ﹤0.01%
105
ARQT icon
1205
Arcutis Biotherapeutics
ARQT
$2.06B
$2K ﹤0.01%
245
BMEA icon
1206
Biomea Fusion
BMEA
$114M
$2K ﹤0.01%
109
DYN icon
1207
Dyne Therapeutics
DYN
$2.02B
$2K ﹤0.01%
210
EWTX icon
1208
Edgewise Therapeutics
EWTX
$1.64B
$2K ﹤0.01%
254
GLPG icon
1209
Galapagos
GLPG
$2.2B
$2K ﹤0.01%
51
HCM icon
1210
HUTCHMED
HCM
$2.74B
$2K ﹤0.01%
185
HLVX icon
1211
HilleVax
HLVX
$105M
$2K ﹤0.01%
134
ITOS
1212
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
KNSA icon
1213
Kiniksa Pharmaceuticals
KNSA
$2.65B
$2K ﹤0.01%
139
KURA icon
1214
Kura Oncology
KURA
$713M
$2K ﹤0.01%
227
NRIX icon
1215
Nurix Therapeutics
NRIX
$758M
$2K ﹤0.01%
152
NVAX icon
1216
Novavax
NVAX
$1.28B
$2K ﹤0.01%
291
PHAT icon
1217
Phathom Pharmaceuticals
PHAT
$875M
$2K ﹤0.01%
167
QURE icon
1218
uniQure
QURE
$985M
$2K ﹤0.01%
158
QYLD icon
1219
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.22B
0
RAPT icon
1220
RAPT Therapeutics
RAPT
$214M
$2K ﹤0.01%
13
SPRY icon
1221
ARS Pharmaceuticals
SPRY
$995M
$2K ﹤0.01%
367
SRRK icon
1222
Scholar Rock
SRRK
$3.02B
$2K ﹤0.01%
208
TARS icon
1223
Tarsus Pharmaceuticals
TARS
$2.43B
$2K ﹤0.01%
107
TBPH icon
1224
Theravance Biopharma
TBPH
$703M
$2K ﹤0.01%
215
TSVT
1225
DELISTED
2seventy bio
TSVT
$2K ﹤0.01%
152